Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ryo Okuda
Observed names:
Okuda Ryo,
Okuda, R.,
R Okuda,
R. Okuda
Institutions:
Kanagawa Cardiovascular and Respiratory Center,
Osaka Metropolitan University
Observed institutions:
Tokyo Medical University Ibaraki Medical Center,
Tokyo Women's Medical University,
Kanagawa Cardiovascular and Respiratory Center,
Saitama Red Cross Hospital,
Osaka Metropolitan University,
Yokohama City University
show all 6
ORCID:
0000-0001-8691-7773
Observed ORCID:
0000-0001-8691-7773
OpenAlex ID:
A5026719164
Works
94
Awards
1
Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice
2013
·
Ryo Okuda
, Eri Hagiwara
, et al.
·
Respiratory Medicine
·
99
Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion
2019
·
Tomoyuki Fujisawa
, Kazutaka Mori
, et al.
·
European Respiratory Journal
·
96
PDF
Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study
2016
·
Akimasa Sekine
, Hiroaki Satoh
, et al.
·
Cancer Chemotherapy and Pharmacology
·
58
Predictive Factors for the Long-Term Deterioration of Pulmonary Function in Interstitial Lung Disease Associated with Anti-Aminoacyl-tRNA Synthetase Antibodies
2018
·
Hideaki Yamakawa
, Eri Hagiwara
, et al.
·
Respiration
·
51
Cellular senescence and senescence-associated secretory phenotype: comparison of idiopathic pulmonary fibrosis, connective tissue disease-associated interstitial lung disease, and chronic obstructive pulmonary disease
2019
·
Ryo Okuda
, Kazutetsu Aoshiba
, et al.
·
Journal of Thoracic Disease
·
50
PDF
Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis
2017
·
Satoshi Ikeda
, Akimasa Sekine
, et al.
·
Scientific Reports
·
44
PDF
Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases
2020
·
Kota Murohashi
, Eri Hagiwara
, et al.
·
Respiratory Investigation
·
37
PDF
Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis
2019
·
Satoshi Ikeda
, Akimasa Sekine
, et al.
·
BMC Pulmonary Medicine
·
30
PDF
Unilateral Upper Lung Field Pulmonary Fibrosis Radiologically Consistent with Pleuroparenchymal Fibroelastosis after Thoracotomy: A New Disease Entity Related to Thoracotomy
2017
·
Akimasa Sekine
, Hiroaki Satoh
, et al.
·
Respiration
·
30
Tolerability and safety of nintedanib in elderly patients with idiopathic pulmonary fibrosis
2020
·
Yoshinori Uchida
, Satoshi Ikeda
, et al.
·
Respiratory Investigation
·
25
Soluble intercellular adhesion molecule-1 for stable and acute phases of idiopathic pulmonary fibrosis
2015
·
Ryo Okuda
, Hidekazu Matsushima
, et al.
·
SpringerPlus
·
25
PDF
Safety of pyrazinamide-including regimen in late elderly patients with pulmonary tuberculosis: A prospective randomized open-label study
2019
·
Eri Hagiwara
, Yoshihiro Suido
, et al.
·
Journal of Infection and Chemotherapy
·
23
Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019
2021
·
Takafumi Yamaya
, Eri Hagiwara
, et al.
·
Respiratory Investigation
·
21
PDF
Low starting-dosage of nintedanib for the reduction of early termination
2019
·
Satoshi Ikeda
, Akimasa Sekine
, et al.
·
Respiratory Investigation
·
20
Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesity
2020
·
Akimasa Sekine
, Satoshi Wasamoto
, et al.
·
Respiratory Investigation
·
19
Unilateral upper lung-field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis after thoracic surgery: Clinical and radiological courses with autopsy findings
2020
·
Akimasa Sekine
, Hiroaki Satoh
, et al.
·
Respiratory Investigation
·
19
Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia
2019
·
Hideaki Yamakawa
, Eri Hagiwara
, et al.
·
Respiratory Investigation
·
18
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
2022
·
Satoshi Ikeda
, Akimasa Sekine
, et al.
·
Medicine
·
14
Acute Exacerbation and Proposed Criteria for Progressive Pulmonary Fibrosis in Patients with Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
2023
·
Ryo Okuda
, Tamiko Takemura
, et al.
·
Respiration
·
13
Efficacy and safety of inhaled N-acetylcysteine in idiopathic pulmonary fibrosis: A prospective, single-arm study
2015
·
Ryo Okuda
, Hidekazu Matsushima
, et al.
·
Respiratory Investigation
·
13
Inhalation challenge test using pigeon eggs for chronic hypersensitivity pneumonitis
2020
·
Ryo Okuda
, Tamiko Takemura
, et al.
·
Clinical & Experimental Allergy
·
12
Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
2019
·
Ryo Okuda
, Eri Hagiwara
, et al.
·
Sarcoidosis vasculitis and diffuse lung diseases
·
12
PDF
Clinical characteristics and early outcomes of patients newly diagnosed with pulmonary Mycobacterium avium complex disease
2018
·
Eri Hagiwara
, Takuma Katano
, et al.
·
Respiratory Investigation
·
9
Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase
2022
·
Ryo Okuda
, Tamiko Takemura
, et al.
·
Allergy Asthma and Clinical Immunology
·
8
PDF
Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
2022
·
Akimasa Sekine
, Goushi Matama
, et al.
·
Thoracic Cancer
·
8
PDF
Show more works
View as search
Works count:
94
Citation count:
855
H-index:
17
I10-index:
22
Year
Topic
Type